Quanterix Corporation (QTRX)
NASDAQ:QTRX

Quanterix Stock Analysis & Ratings

Quanterix Stock Analysis Overview

Smart Score
1
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Quanterix stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

QTRX

QTRX Stock Stats

Previous Close$28.45
Open$27.31
Bid13.98 x 5
Ask34.23 x 4
Today’s Range$26.17 - $28.45
52-Week Range$25.32 - $92.57
Volume346.15K
Average Volume267.89K
Market Cap$992.79M
Beta1.48
P/E Ratio-19.9
EPS-1.36
Earnings DateMar 15, 2022

Company Description

Quanterix Corporation

Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.
Sector
Healthcare
Industry
Medical Devices & Instruments
CEO
E. Kevin Hrusovsky
Employees
314
Website
www.quanterix.com
ISIN
US74766Q1013
Address
900 Middlesex Turnpike, Billerica, MA, 01821, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

QTRX FAQ

What was Quanterix’s price range in the past 12 months?
Quanterix lowest stock price was $25.32 and its highest was $92.57 in the past 12 months.
    What is Quanterix’s market cap?
    Quanterix’s market cap is $992.79M.
      What is Quanterix’s price target?
      The average price target for Quanterix is $76.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $92.00 ,the lowest forecast is $60.00. The average price target represents 180.55% Increase from the current price of $27.09.
        What do analysts say about Quanterix?
        Quanterix’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Quanterix’s upcoming earnings report date?
          Quanterix’s upcoming earnings report date is Mar 15, 2022 which is in 48 days.
            How were Quanterix’s earnings last quarter?
            Quanterix released its earnings results on Nov 04, 2021. The company reported -$0.429 earnings per share for the quarter, missing the consensus estimate of -$0.356 by -$0.073.
              Is Quanterix overvalued?
              According to Wall Street analysts Quanterix’s price is currently Undervalued.
                Does Quanterix pay dividends?
                Quanterix does not currently pay dividends.
                What is Quanterix’s EPS estimate?
                Quanterix’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Quanterix have?
                Quanterix has 36,650,000 shares outstanding.
                  What happened to Quanterix’s price movement after its last earnings report?
                  Quanterix reported an EPS of -$0.429 in its last earnings report, missing expectations of -$0.356. Following the earnings report the stock price went up 3.087%.
                    Which hedge fund is a major shareholder of Quanterix?
                    Among the largest hedge funds holding Quanterix’s share is Farallon Capital Management, L.L.C.. It holds Quanterix’s shares valued at 27M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis